Sequencing: Page 2

Bio-Rad, Element Biosciences collaborate on RNA library prep with benchtop sequencer

Bio-Rad will present the results of this collaboration at the Advances in Genome Biology and Technology (AGBT) General Meeting in Hollywood, FL, on Thursday, February 9.

February 8, 2023

Study finds 41% of infant deaths associated with genetic diseases

Researchers have found the genetic disease contribution to infant deaths to be higher than expected; neonatal diagnosis strategies may decrease infant mortality.

February 9, 2023

Exact Sciences launches NGS test for cancer therapy selection

The genomic test identifies tumor DNA and RNA alterations to generate a molecular picture of the patient's cancer. Test results are personalized for each patient to enable precise treatment.

February 7, 2023

VieCure, Labcorp collaborate on clinical workflows, genomic testing

The firms are aiming to assist patient-specific treatment plans by integrating Labcorp’s precision medicine testing with VieCure’s clinical decision-support tool.

January 25, 2023

Thermo Fisher Scientific, AstraZeneca to develop solid tissue and blood-based CDx for NSCLC

The companion diagnostic leverages Thermo Fisher’s Oncomine Dx Express Test on its Genexus Dx System, a fully integrated next-generation sequencing platform, with an automated specimen-to-report workflow that provides results in 24 hours.

January 24, 2023

Thermo Fisher Scientific launches sequencing assay to ID variants that may resist HIV therapies

The assay, which uses HIV RNA extracted from plasma or dried blood spots, is designed to analyze genomic mutations in the protease, reverse transcriptase, and integrase regions of the HIV-1 pol gene across nine subtypes of global significance.

January 24, 2023

Most Popular

Quest launches long-COVID testing panels for consumers

Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing

RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target

Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux

Patients prefer immediate test results, even when the news is bad

Quest Diagnostics offers suite of services for transplant patients and living donors

Qiagen Digital Insights launches NGS analysis to process whole genome for $1 in cloud computing costs

The product incorporates a software accelerator that quickly converts raw sequencing data in FASTQ files from any paired-end short-read sequencing platform into interpretable lists of genetic variants in the VCF format.

January 23, 2023

DNA sequencing method offers peek into genomic black box

University of Cambridge researchers have outlined a new DNA sequencing method that detects where and how small molecule drugs interact with a targeted genome.

January 23, 2023

Jumpcode Genomics enters PacBio’s Compatible Partner program

Jumpcode’s Single Cell RNA Boost Kit is compatible with PacBio’s Multiplexed Arrays Sequencing (MAS-Seq) for 10x Single Cell 3’ kit, which allows researchers to remove uninformative fragments from single-cell RNA sequencing libraries prior to sequencing.

January 12, 2023

Element Biosciences debuts high-throughput update to benchtop sequencer

DNA sequencing technology developer Element Biosciences unveiled a new throughput-based option for its Aviti System that provides high-quality sequencing on a benchtop for as low as $200 a genome, or $2 per gigabase.

January 12, 2023

Qiagen, Helix collaborate to market companion diagnostic products for hereditary diseases

Under the agreement, Qiagen will be the exclusive marketing and contracting partner in the U.S. for Helix’s companion diagnostic services.

January 5, 2023

Alercell preparing January launch of sequencing test for leukemia

The Montana-based firm also aims to launch a methylation-based molecular diagnostic test for lung cancer later in the first quarter of 2023.

December 29, 2022

Previous Page

Page 2 of 42

Next Page